Where does Guardant Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Guardant Health, Inc. ranks #3,132 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Guardant Health, Inc. hold?

Guardant Health, Inc. holds 120 US utility patents granted between 2017 and 2025, spanning 12 technology areas.

What is Guardant Health, Inc.'s Innovation Score?

Guardant Health, Inc. has an Innovation Score of 53.8 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Guardant Health, Inc.'s patent grant rate increasing or decreasing?

Guardant Health, Inc.'s recent grant velocity is +709% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Guardant Health, Inc.'s patents?

Guardant Health, Inc.'s patents average 22.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Guardant Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Guardant Health, Inc.

Q: What technology areas does Guardant Health, Inc. focus on?

Guardant Health, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 110 patents, ranking #35 of 2,502 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 120 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Guardant ranks #3,132 of 49,997 tracked US assignees by granted-patent volume, with 120 patents across 12 technology areas.

#3,132
of 49,997 US assignees by volume: Top 8%
by Innovation Score (53.8/100): 22.3
avg claims per patent: +709%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3132 · US Corporation #3,132 · 120 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 120 grants
TOP-DECILE #3,132/49,997
PHOTO-FINISH Atombeam
CPC-FOCUS C12Q · 12 areas
INNOV-PAR 53.8/100
CLAIMS-DENSE 22.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +709% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Atombeam Technologies Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Guardant’s 53.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.6 pts (31%) Velocity 11.6 pts (22%) Breadth 12.2 pts (23%) Claim depth 13.4 pts (25%)

Qualcomm Incorporated · highest

85
Espressif Systems… · near

54
Guardant Health · this assignee

54
Shenzhen Newsonic · near

54
SimpliSafe · near

54
Spraying Systems · near

54
3D Lighting… · lowest

7

What this shows Guardant's Innovation Score is 53.8/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Guardant?

Each dot is one of Guardant’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Guardant’s own 22.3 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Guardant vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Guardant's grants concentrate

Guardant Health, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 91.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (22 grants) versus a trough of 2 in 2018. By volume, Guardant sits between Toshiba Lighting & Technology Corporation and Linak A/S.

Guardant's three-year grant acceleration

From 2019–2021 to 2022–2024, Guardant Health, Inc. moved from 34 to 59 grants (1.74x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #300. See the growth leaderboard.

Toshiba Lighting…

121
Atombeam

120
Edwards Japan

120
GRG Banking Equip…

120
Guest Tek Interac…

120
Ixia

120
K-tronics (Suzhou…

120
Linak A/S

120
Guardant Health ◀

120

What this shows Guardant holds 120 patents at rank #3,132, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Guardant

By rank, the assignees closest to #3,132 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Guardant's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Guardant, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Guardant ranks #35 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Shenzhen Newsonic Technologies Co., Ltd. 54 Espressif Systems (SHANGHAI) Co., Ltd. 54 SimpliSafe, Inc. 54 Spraying Systems Co. 54

Similar claim depth

Nearest assignees by average claims per patent (22.3 here).

Charter Communications Operating, LLC 22.3 avg Usnr, LLC 22.3 avg First Dome Corporation 22.3 avg Open Text S.A. 22.3 avg

Guardant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Guardant Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	5	4.2%
2018	2	1.7%
2019	4	3.3%
2020	12	10.0%
2021	18	15.0%
2022	16	13.3%
2023	21	17.5%
2024	22	18.3%
2025partial year	20	16.7%

Which technologies does Guardant Health, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 110

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 101

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 35

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 20

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 8

Y02A - Technologies FOR Adaptation TO Climate Change 8

C07K - Peptides 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

G06F - Electric Digital Data Processing 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Guardant Health, Inc.'s patent record in context - here's where to go next.

Guardant Health, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 91.7% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #3,132 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Guardant Health, Inc. against Toshiba Lighting & Technology Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.